6- methyl- N- (1H- tetrazol- 5- yl)- 2- pyridinecarboxamide

Subscribe to Selected New Research on 6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide

2 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: RN & structure given in first source; RN not in Chemline 3/84

Also Known As:

6-MTPC; TA 5707; TA 5707F; TA-5707; TA-5707F

Bio-Agent Context: Research Results

Heterocyclic Compounds: 25

1-Ring Heterocyclic Compounds

Pyridines: 28

Nicotinic Acids: 11

Niacinamide: 975

6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide: 2

Heterocyclic Acids

Nicotinic Acids: 11

Niacinamide: 975

6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide: 2

Related Diseases

1.	Drug Hypersensitivity (Drug Allergy) 07/01/1995 - "Studies on controlled release dosage forms were conducted by using waxy materials for a newly developed anti-allergy drug, 6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide (TA-5707F), which is not maintained at an effective level in blood for a long duration. " Order ALL the reference details at left...
2.	Anaphylaxis (Anaphylactic Shock) 09/01/1987 - "2) TA-5707, at concentrations above 10(-7) M, inhibited antigen-induced histamine release and dye leakage in the rat peritoneal cavity (passive peritoneal anaphylaxis). " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Dosage Forms (Dosage Form)
2.	Antigens

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>